<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="The Cost-utility Analysis of 18-Fluoro-2-Deoxyglucose Positron Emission Tomography in the Diagnosis of Recurrent Nasopharyngeal Carcinoma" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/the-cost-utility-analysis-of-18-fluoro-2-deoxyglucose-positron-emission-tomography-in-the-diagnosis/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/the-cost-utility-analysis-of-18-fluoro-2-deoxyglucose-positron-emission-tomography-in-the-diagnosis/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2008-12-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="The Cost-utility Analysis of 18-Fluoro-2-Deoxyglucose Positron Emission Tomography in the Diagnosis of Recurrent Nasopharyngeal Carcinoma" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-07T07:15:32+00:00","datePublished":"2008-12-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"The Cost-utility Analysis of 18-Fluoro-2-Deoxyglucose Positron Emission Tomography in the Diagnosis of Recurrent Nasopharyngeal Carcinoma","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/the-cost-utility-analysis-of-18-fluoro-2-deoxyglucose-positron-emission-tomography-in-the-diagnosis/"},"url":"https://clinicaltree.github.io/posts/the-cost-utility-analysis-of-18-fluoro-2-deoxyglucose-positron-emission-tomography-in-the-diagnosis/"}</script><title>The Cost-utility Analysis of 18-Fluoro-2-Deoxyglucose Positron Emission Tomography in the Diagnosis of Recurrent Nasopharyngeal Carcinoma | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>The Cost-utility Analysis of 18-Fluoro-2-Deoxyglucose Positron Emission Tomography in the Diagnosis of Recurrent Nasopharyngeal Carcinoma</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>The Cost-utility Analysis of 18-Fluoro-2-Deoxyglucose Positron Emission Tomography in the Diagnosis of Recurrent Nasopharyngeal Carcinoma</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1230742800" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Dec 31, 2008 </em> </span> <span> Updated <em class="" data-ts="1680851732" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 7, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Ruoh-Fang Yen MD PhD</a> </em>, <em> <a href="">Ming-Fang Yen PhD</a> </em>, <em> <a href="">Ruey-Long Hong MD PhD</a> </em>, <em> <a href="">Kai-Yuan Tzen MD</a> </em>, <em> <a href="">Chun-Ru Chien MD</a> </em>, <em> <a href="">Tony Hsiu-Hsi Chen PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1667 words"> <em>9 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>18-Fluoro-2-deoxyglucose (18F-FDG) positron emission tomography (PET) is effective but costly in the early detection of recurrence for nasopharyngeal carcinoma (NPC) in patients after treatment. In this study, we developed a decision tree model to analyze the cost utility of 18F-FDG PET in detecting loco-regional recurrences for NPC patients after therapy.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The analysis for cost utility is based on the decision-tree model for three different strategies: 1) magnetic resonance imaging (MRI)-only, 2) PET-only, and 3) MRI-PET (performing PET if MRI result is uncertain). Sensitivity analyses have been performed to examine changes in the cost ratio of PET/MRI and the probability of uncertain MRI.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>After inputting the data for utilities and life expectancies into the decision tree model, the quality-adjusted life expectancies turn out to be 16.16 quality-adjusted life-years (QALYs) for strategy 1, 16.70 QALYs for strategy 2, and 17.35 QALYs for strategy 3. The additional cost per additional QALYs for strategy 3 relative to strategy 1 is calculated to be US $462. Strategy 3 dominates over strategy 2 because strategy 3 costs less and yields more QALYs than strategy 2. If the cost ratio of PET/MRI is less than 1.85 or the probability of uncertain MRI is greater than 73%, then the PET-only strategy becomes more cost-effective than the MRI-PET strategy.</p><h2 id="conclusion"><span class="mr-2">Conclusion</span><a href="#conclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Our analysis shows that the MRI-PET strategy is the most cost-effective for now. It is likely the PET-only strategy will become the most cost-effective for recurrent NPC in patients in the near future as the cost of PET has decreased in a faster rate than the cost of MRI.</p><p>In Southern China and Southeast Asia, nasopharyngeal carcinoma (NPC) is one of the more common malignant tumors ( ), with an incidence rate of 10–30 persons per 100,000 people per year. The loco-regional recurrence is one of the crucial prognostic factors for NPC patients who have undergone radiotherapy (RT) or RT with adjuvant chemotherapy ( ). The conventional structure based diagnostic tools, such as magnetic resonance imaging (MRI) and computed tomography (CT), have been proved ineffective in the early detection of residual or recurrent foci for NPC patients ( ).</p><p>In contrast, it has been demonstrated in previous studies that 18-fluoro-2-deoxyglucose (18F-FDG) positron emission tomography (PET) is an effective tool for distinguishing recurrent tumors from post-treatment changes, such as tissue necrosis or fibrosis in the nasopharynx ( ). However, 18F-FDG PET scan is not routinely scheduled for the follow-up of NPC patients in our center due to its prohibitive cost. It is performed only when suspicious recurrences have been revealed in the results of other conventional radiologic findings during follow-up.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="decision-analysis-model"><span class="mr-2">Decision Analysis Model</span><a href="#decision-analysis-model" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheCostutilityAnalysisof18Fluoro2DeoxyglucosePositronEmissionTomographyintheDiagnosisofRecurrentNasopharyngealCarcinoma/0_1s20S1076633208004194.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheCostutilityAnalysisof18Fluoro2DeoxyglucosePositronEmissionTomographyintheDiagnosisofRecurrentNasopharyngealCarcinoma/0_1s20S1076633208004194.jpg" alt="Figure 1, The decision tree. FN, false negative; FP, false positive; NPC, nasopharyngeal carcinoma; neg, negative; Pos, positive; Rec, recurrence; TN, true negative; TP, true positive." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="the-baseline-case"><span class="mr-2">The Baseline Case</span><a href="#the-baseline-case" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="probabilities"><span class="mr-2">Probabilities</span><a href="#probabilities" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Probabilities Used in the Decision Tree</p><p>Variables Value (%) Range Reference For MRI-only MRI Sensitivity 60 50–70 MRI Specificity 60 50–70 For PET-only PET Sensitivity (low pretest probability) 70 60–80 PET Specificity (low pretest probability) 70 60–80 For MRI-PET Probability of an indeterminate MRI 50 20–80 MRI Sensitivity 75 65–85 MRI Specificity 75 65–85 PET Sensitivity (high pretest probability) 90 75–95 PET Specificity (high pretest probability) 90 75–95</p><p>MRI, magnetic resonance imaging; PET, positron emission tomography.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="outcome-measures"><span class="mr-2">Outcome Measures</span><a href="#outcome-measures" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="utility"><span class="mr-2">Utility</span><a href="#utility" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 2</p><p>Utilities Estimated from Visual Analog Scale</p><p>Status Utility Standard Deviation Post-initial treatment disease free 0.76 0.14 During treatment for recurrence 0.35 0.15 Recurrence after treatment 0.57 0.18 Recurrence delayed treatment 0.32 0.11</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="life-expectancy"><span class="mr-2">Life expectancy</span><a href="#life-expectancy" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 3</p><p>Life Expectancies for NPC Patients After Initial Chemoradiation without Recurrence, Recurrence with Immediate Treatment, and Recurrence but Delayed Treatment</p><p>Status 5-y Disease-specific Mortality Life Expectancy Reference Recurrence free 0% 32 Recurrence with immediate treatment 50% 7.7 Recurrence but delayed treatment 80% 3.5</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="costs"><span class="mr-2">Costs</span><a href="#costs" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 4</p><p>Costs of Magnetic Resonance Imaging (MRI) and Positron Emission Tomographic (PET) Scans</p><p>Study Cost (US$) MRI scan 350 PET scan 1,100</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="diagnostic-accuracy"><span class="mr-2">Diagnostic accuracy</span><a href="#diagnostic-accuracy" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="cost-utility-analysis"><span class="mr-2">Cost-utility analysis</span><a href="#cost-utility-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>ICUR=[cost(strategyX)−cost(strategyY)]/[utility(strategyX)−utility(strategyY)]. ICUR</p><p>=</p><p>[</p><p>cost</p><p>(</p><p>strategy</p><p>X</p><p>)</p><p>−</p><p>cost</p><p>(</p><p>strategy</p><p>Y</p><p>)</p><p>]</p><p>/</p><p>[</p><p>utility</p><p>(</p><p>strategy</p><p>X</p><p>)</p><p>−</p><p>utility</p><p>(</p><p>strategy</p><p>Y</p><p>)</p><p>]</p><p>.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 5</p><p>Baseline Results from Cost-utility Analysis</p><p>Strategy Cost ($) Diagnostic Accuracy QALY Incremental Cost Per QALY ($) MRI-only 350 0.60 16.16 — PET-only 1100 0.70 16.70 1389 MRI-PET only 900 0.82 17.35 462</p><p>MRI, magnetic resonance imaging; PET, positron emission tomography; QALY, quality-adjusted life years.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="diagnostic-accuracy-1"><span class="mr-2">Diagnostic Accuracy</span><a href="#diagnostic-accuracy-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="qalys"><span class="mr-2">QALYs</span><a href="#qalys" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="sensitivity-analysis"><span class="mr-2">Sensitivity Analysis</span><a href="#sensitivity-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheCostutilityAnalysisof18Fluoro2DeoxyglucosePositronEmissionTomographyintheDiagnosisofRecurrentNasopharyngealCarcinoma/1_1s20S1076633208004194.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheCostutilityAnalysisof18Fluoro2DeoxyglucosePositronEmissionTomographyintheDiagnosisofRecurrentNasopharyngealCarcinoma/1_1s20S1076633208004194.jpg" alt="Figure 2, Sensitivity analysis showing the relation between the cost-utility ratio (vertical axis) and the cost ratio of positron emission tomography/magnetic resonance imaging (PET/MRI) (horizontal axis). The base case cost ratio is 3.14. The threshold cost ratio is 1.85. For the cost ratio above the threshold value, MRI-PET is the more cost-effective strategy." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheCostutilityAnalysisof18Fluoro2DeoxyglucosePositronEmissionTomographyintheDiagnosisofRecurrentNasopharyngealCarcinoma/2_1s20S1076633208004194.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheCostutilityAnalysisof18Fluoro2DeoxyglucosePositronEmissionTomographyintheDiagnosisofRecurrentNasopharyngealCarcinoma/2_1s20S1076633208004194.jpg" alt="Figure 3, Sensitivity analysis showing the relation between the cost-utility ratio (vertical axis) and the probability of magnetic resonance imaging (MRI) indeterminate (horizontal axis). The baseline probability is 50%. The threshold probability is 73%. For the probability of uncertain MRI below this value, MRI-PET is the more cost-effective strategy. PET, positron emission tomography." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheCostutilityAnalysisof18Fluoro2DeoxyglucosePositronEmissionTomographyintheDiagnosisofRecurrentNasopharyngealCarcinoma/3_1s20S1076633208004194.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheCostutilityAnalysisof18Fluoro2DeoxyglucosePositronEmissionTomographyintheDiagnosisofRecurrentNasopharyngealCarcinoma/3_1s20S1076633208004194.jpg" alt="Figure 4, Two-way sensitivity analysis between the cost ratio of positron emission tomography/magnetic resonance imaging (PET/MRI) (vertical axis) and the probability of uncertain MRI (horizontal axis). The base case is shown as X. In the non-shaded region below the line, PET-only is the preferred strategy." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusion-1"><span class="mr-2">Conclusion</span><a href="#conclusion-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="acknowledgment"><span class="mr-2">Acknowledgment</span><a href="#acknowledgment" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Huang D.P.: Epidemiology of nasopharyngeal carcinoma. Ear Nose Throat J 1990; 69: pp. 222-225.</p><li><p>2. Liu M.T., Hsieh C.Y., Chang T.H., Lin J.P., Huang C.C., Wang A.Y.: Prognostic factors affecting the outcome of nasopharyngeal carcinoma. Jpn J Clin Oncol 2003; 33: pp. 501-508.</p><li><p>3. Farias T.P., Dias F.L., Lima R.A., et. al.: Prognostic factors and outcome for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2003; 129: pp. 794-799.</p><li><p>4. Chong V.F., Fan Y.F.: Detection of recurrent nasopharyngeal carcinoma: MR imaging versus CT. Radiology 1997; 202: pp. 463-470.</p><li><p>5. Ng S.H., Chang J.T., Ko S.F., Wan Y.L., Tang L.M., Chen W.C.: MRI in recurrent nasopharyngeal carcinoma. Neuroradiology 1999; 41: pp. 855-862.</p><li><p>6. Olmi P., Fallai C., Colagrande S., Giannardi G.: Staging and follow-up of nasopharyngeal carcinoma: magnetic resonance imaging versus computerized tomography. Int J Radiat Oncol Biol Phys 1995; 32: pp. 795-800.</p><li><p>7. Kao C.H., ChangLai S.P., Chieng P.U., Yen R.F., Yen T.C.: Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. J Clin Oncol 1998; 16: pp. 3550-3555.</p><li><p>8. Kao C.H., Shiau Y.C., Shen Y.Y., Yen R.F.: Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tompgraphy and conputed tomography. Cancer 2002; 94: pp. 1981-1986.</p><li><p>9. Yen R.F., Hung R.L., Pan M.H., Wang Y.H., Huang K.M., Lui L.T., et. al.: 18-fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging. Cancer 2003; 98: pp. 283-287.</p><li><p>10. Ng S.H., Chang T.C., Chan S.C.: Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence. J Nucl Med 2004; 45: pp. 1669-1676.</p><li><p>11. Yen R.F., Hong R.L., Tzen K.Y., Pan M.H., Chen T.H.: Whole-body 18-fluoro-2-deoxyglucose positron emission tomography in recurrent/metastatic nasopharyngeal carcinoma. J Nucl Med 2005; 46: pp. 770-774.</p><li><p>12. Tsai M.H., Shiau Y.C., Kao C.H., Shen Y.Y., Lin C.C., Lee C.C.: Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy. J Cancer Res Clin Oncol 2002; 128: pp. 279-282.</p><li><p>13. Goerres G.W., Mosna-Firlejczyk K., Steurer J., von Schulthess G.K., Bachmann L.M.: Assessment of clinical utility of 18F-FDG PET in patients with head and neck cancer: a probability analysis. Eur J Nucl Med Mol Imaging 2003; 30: pp. 562-571.</p><li><p>14. Gold M.R.Siegel J.E.Russell L.B.Weinstein M.C.Cost-effectiveness in health and medicine.1996.Oxford University PressNew York:</p><li><p>15. Elliot R., Payne K.: Essentials of economic evaluation in healthcare.2005.Pharmaceutical PressLondon</p><li><p>16. Cooper J.S., Scott C., Marcial V., et. al.: The relationship of nasopharyngeal carcinomas and second independent malignancies based on the Radiation Therapy. Cancer 1991; 67: pp. 1673-1677.</p><li><p>17. Sham J.S., Wei W.I., Tai P.T., Choy D.: Multiple malignant neoplasms in patients with nasopharyngeal carcinoma. Oncology 1990; 47: pp. 471-474.</p><li><p>18. Beck J.R., Kassirer J.P., Pauker S.G.: A convenient approximation of life expectancy (the “DEALE”): I. Am J Med 1982; 73: pp. 883-888.</p><li><p>19. Chua D.T., Wei W.I., Sham J.S., Chen A.C., Au G.: Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma. Head Neck 2003; 25: pp. 585-594.</p><li><p>20. Poon D., Yap s.p., Wong Z.W., et. al.: Concurrent chemoradiotherapy in locoregionally recurrent nasopharyneal carcinoma. Int J Radiat Oncol Biol Phys 2004; 59: pp. 1312-1318.</p><li><p>21. Shin S.S., Ahn Y.C., Lim do H., Park W., Huh S.J.: High dose 3-dimensional re-irradiation for locally recurrent nasopharyngeal cancer. Yonsei Med J 2004; 45: pp. 100-106.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-16/'>Volume 16</a>, <a href='/categories/issue-1/'>Issue 1</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=The%20Cost-utility%20Analysis%20of%2018-Fluoro-2-Deoxyglucose%20Positron%20Emission%20Tomography%20in%20the%20Diagnosis%20of%20Recurrent%20Nasopharyngeal%20Carcinoma%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fthe-cost-utility-analysis-of-18-fluoro-2-deoxyglucose-positron-emission-tomography-in-the-diagnosis%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=The%20Cost-utility%20Analysis%20of%2018-Fluoro-2-Deoxyglucose%20Positron%20Emission%20Tomography%20in%20the%20Diagnosis%20of%20Recurrent%20Nasopharyngeal%20Carcinoma%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fthe-cost-utility-analysis-of-18-fluoro-2-deoxyglucose-positron-emission-tomography-in-the-diagnosis%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fthe-cost-utility-analysis-of-18-fluoro-2-deoxyglucose-positron-emission-tomography-in-the-diagnosis%2F&text=The%20Cost-utility%20Analysis%20of%2018-Fluoro-2-Deoxyglucose%20Positron%20Emission%20Tomography%20in%20the%20Diagnosis%20of%20Recurrent%20Nasopharyngeal%20Carcinoma%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/a-feasibility-study-on-model-based-evaluation-of-kidney-perfusion-measured-by-means-of-fair-prepared/"><div class="card-body"> <em class="small" data-ts="1230742800" data-df="ll" > Dec 31, 2008 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Feasibility Study on Model-based Evaluation of Kidney Perfusion Measured by Means of FAIR Prepared True-FISP Arterial Spin Labeling (ASL) on a 3-T MR Scanner</h3><div class="text-muted small"><p> Rationale and Objectives A feasibility study on measuring kidney perfusion by a contrast-free magnetic resonance (MR) imaging technique is presented. Materials and methods A flow-sensitive alter...</p></div></div></a></div><div class="card"> <a href="/posts/abstracts-of-funded-national-institutes-of-health-grants/"><div class="card-body"> <em class="small" data-ts="1230742800" data-df="ll" > Dec 31, 2008 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Abstracts of Funded National Institutes of Health Grants</h3><div class="text-muted small"><p> The following abstracts of diagnostic radiology research and training grants funded by the National Institutes of Health (NIH) were awarded to principal investigators (PIs) whose primary appointmen...</p></div></div></a></div><div class="card"> <a href="/posts/assessment-of-radiologist-performance-in-the-detection-of-lung-nodules/"><div class="card-body"> <em class="small" data-ts="1230742800" data-df="ll" > Dec 31, 2008 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Assessment of Radiologist Performance in the Detection of Lung Nodules</h3><div class="text-muted small"><p> Rationale and Objectives Studies that evaluate the lung nodule detection performance of radiologists or computerized methods depend on an initial inventory of the nodules within the thoracic image...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/the-bookshelf/" class="btn btn-outline-primary" prompt="Older"><p>The bookshelf</p></a> <a href="/posts/4-d-imaging-in-cerebrovascular-disorders-by-using-320-slice-ct/" class="btn btn-outline-primary" prompt="Newer"><p>4-D Imaging in Cerebrovascular Disorders by Using 320-Slice CT</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
